ARCHIVES

Bristol-Myers Squibb Board Removes CEO Peter Dolan Over Plavix Deal. Two Republican Senators Say They Will Place Holds On Confirmation of Andrew von Eschenbach as FDA Commissioner. Craig Thompson Named Director of Abramson Cancer Center.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

Why Shouldn’t Scientific Issues Be Discussed In Open Meetings? Editorial

November 10, 1989

Zinder Report Asks VCP To Switch Most Research To Grants, Spread Work Among More Scientists, Change Review Groups

March 22, 1974

NCI-Approved Clinical Trials

December 31, 2004

“With resources now constrained, the ability of NCI to be responsive to its constituencies has been compromised.”

July 7, 1995

Senate Appropriations Include Cancer Control, Training Money, But Very Little for Construction

July 8, 1988

FDA Simplifies Reporting Of Adverse Events

June 18, 1993